These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14564081)

  • 1. Induction of atherosclerosis by human chylomicron remnants: a hypothesis.
    Wilhelm MG; Cooper AD
    J Atheroscler Thromb; 2003; 10(3):132-9. PubMed ID: 14564081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma.
    Mamo JC; Proctor SD; Smith D
    Atherosclerosis; 1998 Dec; 141 Suppl 1():S63-9. PubMed ID: 9888645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
    Staprans I; Pan XM; Rapp JH; Feingold KR
    Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins.
    Zilversmit DB
    Clin Chem; 1995 Jan; 41(1):153-8. PubMed ID: 7813071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct interaction of dietary lipids carried in chylomicron remnants with cells of the artery wall: implications for atherosclerosis development.
    Botham KM; Bravo E; Elliott J; Wheeler-Jones CP
    Curr Pharm Des; 2005; 11(28):3681-95. PubMed ID: 16305504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of triglyceride-rich lipoproteins in atherogenesis.
    Zilversmit DB
    Ann N Y Acad Sci; 1976; 275():138-44. PubMed ID: 188364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial intimal retention of pro-atherogenic lipoproteins in insulin deficient rabbits and rats.
    Proctor SD; Pabla CK; Mamo JC
    Atherosclerosis; 2000 Apr; 149(2):315-22. PubMed ID: 10729381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial lipoproteins and atherosclerosis.
    Yu KC; Cooper AD
    Front Biosci; 2001 Mar; 6():D332-54. PubMed ID: 11229885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disturbances in dietary fat metabolism and their role in the development of atherosclerosis.
    Weintraub M; Charach G; Grosskopf I
    Biomed Pharmacother; 1997; 51(8):311-3. PubMed ID: 9436521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins.
    Proctor SD; Mamo JC
    Coron Artery Dis; 1996 Mar; 7(3):239-45. PubMed ID: 8827411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the effects of chylomicron remnants on endothelial function by minor dietary lipid components.
    Perona JS; Cabello-Moruno R; Ruiz-Gutierrez V
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):446-50. PubMed ID: 17511624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octogenarian subjects have low postprandial levels of chylomicron remnants: a possible explanation for protection against atherosclerosis.
    Weintraub M; Ringel Y; Rassin T; Arad J; Bodner G; Liron M
    J Gerontol; 1992 Nov; 47(6):B209-13. PubMed ID: 1430850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chylomicron remnants regulate early growth response factor-1 in vascular smooth muscle cells.
    Takahashi Y; Fujioka Y; Takahashi T; Domoto K; Takahashi A; Taniguchi T; Ishikawa Y; Yokoyama M
    Life Sci; 2005 Jun; 77(6):670-82. PubMed ID: 15921998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remnant lipoproteins as therapeutic targets.
    Havel RJ
    Curr Opin Lipidol; 2000 Dec; 11(6):615-20. PubMed ID: 11086335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.
    Huff MW
    Can J Clin Pharmacol; 2003; 10 Suppl A():26A-32A. PubMed ID: 14571303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin.
    Mamo JC; Wheeler JR
    Coron Artery Dis; 1994 Aug; 5(8):695-705. PubMed ID: 8000623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chylomicron remnants induce monocyte chemoattractant protein-1 expression via p38 MAPK activation in vascular smooth muscle cells.
    Domoto K; Taniguchi T; Takaishi H; Takahashi T; Fujioka Y; Takahashi A; Ishikawa Y; Yokoyama M
    Atherosclerosis; 2003 Dec; 171(2):193-200. PubMed ID: 14644387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary fat and physiological determinants of plasma chylomicron remnant homoeostasis in normolipidaemic subjects: insight into atherogenic risk.
    Irawati D; Mamo JC; Slivkoff-Clark KM; Soares MJ; James AP
    Br J Nutr; 2017 Feb; 117(3):403-412. PubMed ID: 28215212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants.
    Karpe F; Olivecrona T; Hamsten A; Hultin M
    J Lipid Res; 1997 May; 38(5):949-61. PubMed ID: 9186912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.